<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: oa--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">12771983</article-id><article-id pub-id-type="pmc">2377144</article-id><article-id pub-id-type="pii">6600948</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6600948</article-id><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title>Cancer survival in parents who lost a child: a nationwide study in Denmark</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name><surname>Johansen</surname><given-names>C</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Olsen</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><sup>1</sup>The Danish Epidemiology Science Centre, Department of Epidemiology and Social Medicine, University of Aarhus, Vennelyst Boulevard 6, DK-8000 Aarhus C, Denmark</aff><aff id="aff2"><label>2</label><sup>2</sup>Department of Psychosocial Cancer Research, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:jl@soci.au.dk">jl@soci.au.dk</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>05</month><year>2003</year></pub-date><pub-date pub-type="ppub"><day>02</day><month>06</month><year>2003</year></pub-date><volume>88</volume><issue>11</issue><fpage>1698</fpage><lpage>1701</lpage><history><date date-type="received"><day>17</day><month>01</month><year>2003</year></date><date date-type="rev-recd"><day>05</day><month>03</month><year>2003</year></date><date date-type="accepted"><day>07</day><month>03</month><year>2003</year></date></history><copyright-statement>Copyright 2003, Cancer Research UK</copyright-statement><copyright-year>2003</copyright-year><permissions><copyright-holder>Cancer Research UK</copyright-holder></permissions><kwd-group><kwd>survival</kwd><kwd>psychological stress</kwd><kwd>bereavement</kwd><kwd>epidemiology</kwd></kwd-group></article-meta></front><body><p>Psychological stress may alter immune function that could influence tumour growth and metastasis (<xref ref-type="other" rid="bib7">Cohen and Rabin, 1998</xref>; <xref ref-type="other" rid="bib14">Kiecolt-Glaser and Glaser, 1999</xref>), but whether stress is associated with cancer survival is not clear (<xref ref-type="other" rid="bib9">Funch and Marshall, 1983</xref>; <xref ref-type="other" rid="bib13">Jamison <italic>et al</italic>, 1987</xref>; <xref ref-type="other" rid="bib19">Levy <italic>et al</italic>, 1988</xref>; <xref ref-type="other" rid="bib27">Tross <italic>et al</italic>, 1996</xref>; <xref ref-type="other" rid="bib18">Levav <italic>et al</italic>, 2000</xref>). It has been proposed recently that stress may have no obvious effect on overall cancer survival, but could affect survival for specific cancers (<xref ref-type="other" rid="bib4">Andersen <italic>et al</italic>, 1994</xref>; <xref ref-type="other" rid="bib17">Kvikstad <italic>et al</italic>, 1995</xref>). However, previous studies have often been flawed by inadequate control of confounders, loss to follow-up, small sample sizes, and lack of tumour-specific information (<xref ref-type="other" rid="bib25">Ross <italic>et al</italic>, 2002</xref>). Furthermore, self-reported stress in most previous studies is vulnerable to bias (<xref ref-type="other" rid="bib21">Macleod <italic>et al</italic>, 2002</xref>).</p><p>The death of a child is one of the greatest stresses (<xref ref-type="other" rid="bib1">American Psychiatric Association, 1987</xref>), and may produce depression, despair, anxiety, guilt, anger, hostility, and hopelessness (<xref ref-type="other" rid="bib22">Osterweis <italic>et al</italic>, 1984</xref>; <xref ref-type="other" rid="bib26">Rubin and Malkinson, 2001</xref>). In addition, bereaved parents may have more somatic complaints, interpersonal difficulties, and react with more adverse health behaviours (<xref ref-type="other" rid="bib22">Osterweis <italic>et al</italic>, 1984</xref>; <xref ref-type="other" rid="bib2">Anda <italic>et al</italic>, 1990</xref>; <xref ref-type="other" rid="bib6">Camacho <italic>et al</italic>, 1991</xref>; <xref ref-type="other" rid="bib26">Rubin and Malkinson, 2001</xref>), which could be detrimental to health. Few studies have explored the health consequences of parental bereavement on cancer survival (<xref ref-type="other" rid="bib16">Kvikstad and Vatten, 1996</xref>; <xref ref-type="other" rid="bib18">Levav <italic>et al</italic>, 2000</xref>).</p><p>We investigated the effect of the death of a child on the overall and specific cancer survival in parents who lost a child. By using the data from nationwide registers, we had the opportunities to collect accurate information on exposure and follow-up, and detailed data on socioeconomic factors for confounder control.</p><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Study design and data collection</title><p>The cohort has been described elsewhere (<xref ref-type="other" rid="bib20">Li <italic>et al</italic>, 2002</xref>). In short, we recruited all 21&#x02009;062 parents who lost a child from 1980 to 1996, together with 293&#x02009;745 randomly selected parents who had not lost a child. Among the bereaved parents, 461 had a subsequent incident cancer and they were selected to the exposed cohort. Among the parents who did not lose a child, 6237 had an incident cancer after the recruitment and they were included into the unexposed cohort. We collected information on cohort members (date of birth, date of death, gender, school education, residence, cause of death, cancer incidence) from the Prevention Register and The Danish Cancer Registry (<xref ref-type="other" rid="bib24">Roed <italic>et al</italic>, 1999</xref>; <xref ref-type="other" rid="bib8">Danish National Board of Health, 2000</xref>). Identification and linkage was based upon the unique personal identification number assigned to all residents in Denmark since 1968 (<xref ref-type="other" rid="bib24">Roed <italic>et al</italic>, 1999</xref>).</p><p>For cancer survival, follow-up started when participants were diagnosed with cancer and ended on date of death, emigration, or 31 December 1997, whichever came first. The main outcomes of interest were overall cancer survival, survival for site-specific cancers, and five subgroups of cancers in which stress could play a role in the aetiology: smoking-related cancers (ICD7 codes 140, 141, 143&#x02013;150, 157, 160&#x02013;162, 180, and 181), alcohol-related cancers (ICD7 codes 141, 143&#x02013;146, 148&#x02013;150, 155, and 161), virus and immune-related cancers (ICD 7 codes 155, 171, 191, 200&#x02013;202, 204), lymphatic&#x0002f;haematopoietic tissue cancers (ICD 7 codes 200&#x02013;205) and hormone-related cancers (ICD 7 codes 170, 172, 175, 177).</p></sec><sec><title>Statistical analysis</title><p>Cox proportional-hazards regressions were fitted to obtain the hazard ratios of dying with cancer, and to estimate 95&#x00025; confidence intervals (CIs). Sociodemographic characteristics of the cohort members, such as age at entry (&#x0003c;30, 30&#x02013;39, 40&#x0002b;years), sex (male, female), school education (basic, secondary or higher, no information), and residence (cities with a population of more than 100&#x02009;000 inhabitants, other places) were included in the models as potential confounders.</p><p>We examined the relative risk in cancer survival between exposed and unexposed cohort members by length of time from the study entry (exposure) to cancer diagnosis (0&#x02013;4, 5&#x02013;8, 9&#x02013;12, &#x02a7e;12 years), and also according to age, gender, and type of death of the deceased child (unexpected death (sudden death by unknown cause, ICD8 codes 795.0&#x02013;795.9, ICD 10 codes R95&#x02013;R97, motor vehicle accidents, ICD8 codes 810.0&#x02013;823.0, ICD10 codes V01&#x02013;V89, suicide, ICD8 codes 950.0&#x02013;959.9, ICD10 codes X60&#x02013;X84, other accidents and violence, ICD8 codes 800.0&#x02013;807.9, 825.0&#x02013;949.9, 960.0&#x02013;999.9, ICD10 codes V90&#x02013;V99, W00&#x02013;X59, X85-Y89) or death by other causes).</p><p>Similar analytic strategies were also applied to subgroups of cancers, and specific cancers with short or long expected survival (<xref ref-type="other" rid="bib12">International Agency for Research on Cancer, World Health Organization, European Commision, 1999</xref>).</p></sec></sec><sec><title>RESULTS</title><p>A total of 135 parents died of cancer among 461 incident cases in the exposed cohort, and 1630 parents died of cancer among 6237 incident cases in the unexposed group. The overall hazard ratios (HRs) for dying from cancer for both parents, fathers, and mothers in the exposed cohort were 1.23 (95&#x00025; confidence interval 1.03&#x02013;1.47), 1.26 (0.98&#x02013;1.63), and 1.19 (0.93&#x02013;1.52), respectively. We found no clear indication of a higher relative mortality rate in cancer patients diagnosed shortly after the bereavement (<xref rid="tbl1" ref-type="table">Table 1</xref><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p content-type="table-title">Hazard ratio (HRs)<sup>a</sup> of dying in bereaved cancer parents grouped by the time from recruitment to cancer diagnosis, Denmark 1980-1997</p></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="center" valign="top" charoff="50"><bold>HR (95&#x00025;CI)</bold><hr/></th></tr><tr><th align="left" valign="top" charoff="50"><bold>Time from onset of bereavement to cancer diagnosis</bold></th><th align="center" valign="top" charoff="50"><bold>Parents</bold></th><th align="center" valign="top" charoff="50"><bold>Fathers</bold></th><th align="center" valign="top" charoff="50"><bold>Mothers</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">All</td><td align="center" valign="top" charoff="50">1.23 (1.03&#x02013;1.47)</td><td align="center" valign="top" charoff="50">1.26 (0.98&#x02013;1.63)</td><td align="center" valign="top" charoff="50">1.19 (0.93&#x02013;1.52)</td></tr><tr><td align="left" valign="top" charoff="50">0&#x02013;4 years</td><td align="center" valign="top" charoff="50">1.15 (0.79&#x02013;1.69)</td><td align="center" valign="top" charoff="50">1.59 (0.89&#x02013;2.85)</td><td align="center" valign="top" charoff="50">0.93 (0.56&#x02013;1.57)</td></tr><tr><td align="left" valign="top" charoff="50">5&#x02013;8 years</td><td align="center" valign="top" charoff="50">1.28 (0.92&#x02013;1.77)</td><td align="center" valign="top" charoff="50">1.32 (0.82&#x02013;2.12)</td><td align="center" valign="top" charoff="50">1.26 (0.81&#x02013;1.99)</td></tr><tr><td align="left" valign="top" charoff="50">9&#x02013;12 years</td><td align="center" valign="top" charoff="50">1.31 (0.93&#x02013;1.85)</td><td align="center" valign="top" charoff="50">1.16 (0.67&#x02013;2.01)</td><td align="center" valign="top" charoff="50">1.45 (0.93&#x02013;2.25)</td></tr><tr><td align="left" valign="top" charoff="50">&#x0003e;12 years</td><td align="center" valign="top" charoff="50">1.15 (0.78&#x02013;1.69)</td><td align="center" valign="top" charoff="50">1.21 (0.76&#x02013;1.95)</td><td align="center" valign="top" charoff="50">1.11 (0.58&#x02013;2.13)</td></tr></tbody></table><table-wrap-foot><fn id="tbfnote1"><label>a</label><p>HR&#x0003d;hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family</p></fn></table-wrap-foot></table-wrap>).</p><p>Age, gender, and cause of death of the deceased child did not significantly modify cancer survival between exposed and unexposed parents (data not shown). The HR of dying from cancer did not differ in bereaved parents according to age, school education, residence place, the number of children in the family, or the number of parents in the family (data not shown).</p><p><xref rid="tbl2" ref-type="table">Table 2</xref><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p content-type="table-title">Hazard ratios (HRs)<sup>a</sup> of dying in cancer parents by cancer groups<sup>b</sup>, Denmark 1980&#x02013;1997</p></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="center" valign="top" charoff="50"><bold>HR (95&#x00025; CI)</bold><hr/></th></tr><tr><th align="left" valign="top" charoff="50"><bold>Cancer groups</bold></th><th align="center" valign="top" charoff="50"><bold>Parents</bold></th><th align="center" valign="top" charoff="50"><bold>Fathers</bold></th><th align="center" valign="top" charoff="50"><bold>Mothers</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Cancer in the digestive system</td><td align="center" valign="top" charoff="50">1.23 (0.85&#x02013;1.78)</td><td align="center" valign="top" charoff="50">0.97 (0.60&#x02013;1.56)</td><td align="center" valign="top" charoff="50">1.22 (0.70&#x02013;2.13)</td></tr><tr><td align="left" valign="top" charoff="50">Cancers in the respiratory system</td><td align="center" valign="top" charoff="50">0.95 (0.65&#x02013;1.40)</td><td align="center" valign="top" charoff="50">0.84 (0.52&#x02013;1.34)</td><td align="center" valign="top" charoff="50">0.92 (0.47&#x02013;1.77)</td></tr><tr><td align="left" valign="top" charoff="50">Smoking-related cancers</td><td align="center" valign="top" charoff="50">1.02 (0.74&#x02013;1.40)</td><td align="center" valign="top" charoff="50">0.99 (0.66&#x02013;1.48)</td><td align="center" valign="top" charoff="50">1.06 (0.66&#x02013;1.76)</td></tr><tr><td align="left" valign="top" charoff="50">Alcohol-related cancers</td><td align="center" valign="top" charoff="50">1.74 (0.80&#x02013;3.77)</td><td align="center" valign="top" charoff="50">1.99 (0.81&#x02013;4.85)</td><td align="center" valign="top" charoff="50">1.59 (0.30&#x02013;8.41)</td></tr><tr><td align="left" valign="top" charoff="50">Virus&#x0002f;immune-related cancers</td><td align="center" valign="top" charoff="50">1.08 (0.67&#x02013;1.73)</td><td align="center" valign="top" charoff="50">0.96 (0.46&#x02013;1.98)</td><td align="center" valign="top" charoff="50">0.99 (0.55&#x02013;1.79)</td></tr><tr><td align="left" valign="top" charoff="50">Lymphatic&#x0002f;haematopoietic cancers</td><td align="center" valign="top" charoff="50">0.86 (0.39&#x02013;1.88)</td><td align="center" valign="top" charoff="50">1.20 (0.47&#x02013;3.09)</td><td align="center" valign="top" charoff="50">0.45 (0.11&#x02013;1.96)</td></tr><tr><td align="left" valign="top" charoff="50">Hormone-related cancers (mothers)</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">1.36 (0.91&#x02013;2.04)</td></tr></tbody></table><table-wrap-foot><fn id="tbfnote2"><label>a</label><p>HR&#x0003d;hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family</p></fn><fn id="tbfnote3"><label>b</label><p>Smoking-related cancers&#x0003d;ICD 7 codes 140, 141, 143&#x02013;149, 150, 157, 160&#x02013;162, 180, 181; alcohol-related cancers&#x0003d;ICD 7 codes 141, 143&#x02013;146, 148-150, 155, 161; virus&#x0002f;immune-related cancers&#x0003d;ICD 7 codes 155, 171, 191, 200&#x02013;202, 204; lymphatic&#x0002f;haematopoietic cancers&#x0003d;ICD 7 codes 200&#x02013;205; hormone-related cancers&#x0003d;ICD 7 codes 170, 172, 175, 177.</p></fn></table-wrap-foot></table-wrap> shows survival for cancers in digestive organs, respiratory organs, and selected cancer groups. We did not observe any statistically significant increased HRs in any of these groups. Similar results were seen for site-specific cancers classified according to their expected survival (<xref rid="tbl3" ref-type="table">Table 3</xref><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p content-type="table-title">Hazard ratios (HRs)<sup>a</sup> of dying in parents for specific cancers grouped according to, <italic>a priori</italic>, expected 5-year survival<sup>b</sup>: Cox regression</p></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><bold>Cancer sites and expected 5-year survival</bold></th><th align="center" valign="top" charoff="50"><bold>Cases in exposed&#x0002f;unexposed</bold></th><th align="center" valign="top" charoff="50"><bold>Deaths in exposed&#x0002f;unexposed</bold></th><th align="center" valign="top" charoff="50"><bold>HR (95&#x00025; CI)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><italic>Cancers with &#x0003c;40&#x00025; 5-year survival</italic></td><td align="center" valign="top" charoff="50">81&#x0002f;849</td><td align="center" valign="top" charoff="50">54&#x0002f;596</td><td align="center" valign="top" charoff="50">0.96 (0.73&#x02013;1.28)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Oesophagus</td><td align="center" valign="top" charoff="50">5&#x0002f;36</td><td align="center" valign="top" charoff="50">5&#x0002f;22</td><td align="center" valign="top" charoff="50">1.22 (0.33&#x02013;4.51)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Gall bladder</td><td align="center" valign="top" charoff="50">3&#x0002f;22</td><td align="center" valign="top" charoff="50">3&#x0002f;12</td><td align="center" valign="top" charoff="50">1.54 (0.18&#x02013;12.93)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Stomach</td><td align="center" valign="top" charoff="50">10&#x0002f;101</td><td align="center" valign="top" charoff="50">8&#x0002f;65</td><td align="center" valign="top" charoff="50">1.42 (0.65&#x02013;3.09)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Lung cancer</td><td align="center" valign="top" charoff="50">46&#x0002f;487</td><td align="center" valign="top" charoff="50">29&#x0002f;354</td><td align="center" valign="top" charoff="50">0.85 (0.57&#x02013;1.25)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Acute leukaemia</td><td align="center" valign="top" charoff="50">9&#x0002f;69</td><td align="center" valign="top" charoff="50">3&#x0002f;41</td><td align="center" valign="top" charoff="50">0.59 (0.13&#x02013;2.63)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Pancreas</td><td align="center" valign="top" charoff="50">8&#x0002f;100</td><td align="center" valign="top" charoff="50">6&#x0002f;79</td><td align="center" valign="top" charoff="50">1.92 (0.75&#x02013;4.89)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50"><italic>Cancers with 40&#x02013;75&#x00025; 5-year survival</italic></td><td align="center" valign="top" charoff="50">183&#x0002f;2519</td><td align="center" valign="top" charoff="50">45&#x0002f;548</td><td align="center" valign="top" charoff="50">1.29 (0.93&#x02013;1.72)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Breast (mothers)</td><td align="center" valign="top" charoff="50">99&#x0002f;1380</td><td align="center" valign="top" charoff="50">20&#x0002f;244</td><td align="center" valign="top" charoff="50">1.40 (0.89&#x02013;2.22)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Bone and soft tissue</td><td align="center" valign="top" charoff="50">5&#x0002f;58</td><td align="center" valign="top" charoff="50">1&#x0002f;12</td><td align="center" valign="top" charoff="50">0.33 (0.02&#x02013;6.24)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Colon&#x0002f;rectum</td><td align="center" valign="top" charoff="50">21&#x0002f;253</td><td align="center" valign="top" charoff="50">6&#x0002f;90</td><td align="center" valign="top" charoff="50">0.89 (0.38&#x02013;2.08)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ovary (mothers)</td><td align="center" valign="top" charoff="50">12&#x0002f;173</td><td align="center" valign="top" charoff="50">6&#x0002f;67</td><td align="center" valign="top" charoff="50">1.76 (0.72&#x02013;4.29)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Cervix (mothers)</td><td align="center" valign="top" charoff="50">36&#x0002f;477</td><td align="center" valign="top" charoff="50">7&#x0002f;63</td><td align="center" valign="top" charoff="50">1.33 (0.60&#x02013;2.95)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Prostate (fathers)</td><td align="center" valign="top" charoff="50">5&#x0002f;111</td><td align="center" valign="top" charoff="50">2&#x0002f;57</td><td align="center" valign="top" charoff="50">4.99 (0.72&#x02013;34.76)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50"><italic>Other cancers not included in the above two groups</italic></td><td align="center" valign="top" charoff="50">221&#x0002f;3122</td><td align="center" valign="top" charoff="50">36&#x0002f;486</td><td align="center" valign="top" charoff="50">1.19 (0.84&#x02013;1.67)</td></tr></tbody></table><table-wrap-foot><fn id="tbfnote4"><label>a</label><p>HR: hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family.</p></fn><fn id="tbfnote5"><label>b</label><p>Expected 5-year survival: specific cancers grouped according to the grouping in The EUROCARE-2 Study, 1985&#x02013;89 for aged 15&#x02013;44 years as following: &#x0003c;40&#x00025; (hypopharynx, oesophagus, liver, gall bladder, pancreas, lung, pleura, stomach, acute leukaemia); 40&#x02013;75&#x00025; (colon&#x0002f;rectum, cervix, bone and soft tissue, ovary, prostate, larynx, breast, brain, kidney); other cancers not included in the above two groups.</p></fn></table-wrap-foot></table-wrap>).</p></sec><sec><title>DISCUSSION</title><p>We observed that parents who lost a child had a slightly shorter cancer survival than those who did not lose a child. This slightly shorter survival was not observed in any particular cancer group, nor was it associated with the sex or age of the parents, the type of bereavement, or the time since exposure. The effect could be causal or because of uncontrolled confounding.</p><p>The possible link between psychological stress and cancer survival has generated a literature of contradictory findings. Some earlier studies suggested worse survival for breast cancer patients exposed to stress (<xref ref-type="other" rid="bib9">Funch and Marshall, 1983</xref>; <xref ref-type="other" rid="bib19">Levy <italic>et al</italic>, 1988</xref>). However, these associations have been weak because of methodological limitations, such as insufficient power and inadequate assessment of exposure were present in those studies. Other studies with more tightly defined patient populations, more adequate control for medical and treatment-related factors, failed to provide evidence for a positive association (<xref ref-type="other" rid="bib13">Jamison <italic>et al</italic>, 1987</xref>; <xref ref-type="other" rid="bib27">Tross <italic>et al</italic>, 1996</xref>). Another study including 14&#x02009;669 cancer patients in bereaved middle-aged mothers showed no reduced survival for overall and site-specific cancer survival. The results were similar when stratifying on metastatic status (<xref ref-type="other" rid="bib16">Kvikstad and Vatten, 1996</xref>). In one recent study, cancer survival was not affected by the death of a child among 677 bereaved parents (<xref ref-type="other" rid="bib18">Levav <italic>et al</italic>, 2000</xref>). The results of our study are in line with these negative findings, suggesting that psychological stress does not play any major role in cancer survival.</p><p>We have previously shown that the death of a child was associated with a slightly increased cancer risk in mothers and suggested that stress-related health behaviours may account for this increased risk (<xref ref-type="other" rid="bib20">Li <italic>et al</italic>, 2002</xref>). The observed weak associations in this and the previous study (<xref ref-type="other" rid="bib20">Li <italic>et al</italic>, 2002</xref>) may be because of adaptive lifestyle factors related to stress exposure, or poorer compliance to the medical treatment of the cancer diseases. In addition, disease-related variables or treatment effect, to which we did not have access, may outweigh the influence of psychological stress, if any, on survival (<xref ref-type="other" rid="bib13">Jamison <italic>et al</italic>, 1987</xref>; <xref ref-type="other" rid="bib5">Buddeberg <italic>et al</italic>, 1991</xref>; <xref ref-type="other" rid="bib27">Tross <italic>et al</italic>, 1996</xref>).</p><p>Parents' response to the death of a child could vary with the elapsed time, type of bereavement, and personal characteristics (<xref ref-type="other" rid="bib22">Osterweis <italic>et al</italic>, 1984</xref>; <xref ref-type="other" rid="bib26">Rubin and Malkinson, 2001</xref>). We found, however, no trend in the risk of dying according to time since bereavement, which is congruent with one other study (<xref ref-type="other" rid="bib18">Levav <italic>et al</italic>, 2000</xref>). We did not observe any effect of age and gender of the deceased child, or effect of sudden unexpected bereavement, which may be related to the health outcomes in bereaved parents (<xref ref-type="other" rid="bib22">Osterweis <italic>et al</italic>, 1984</xref>; <xref ref-type="other" rid="bib23">Parkes, 1998</xref>). Personal characteristics such as age, gender, and education were not associated with modified HRs of dying in the cancer patients, either.</p><p>Psychological stress has been suggested to play a role in cancer progression through immune downregulation, poorer repair of damaged DNA, and alterations in apoptosis (<xref ref-type="other" rid="bib7">Cohen and Rabin, 1998</xref>; <xref ref-type="other" rid="bib14">Kiecolt-Glaser and Glaser, 1999</xref>). Some have suggested that stress is involved in the causation of breast, colo-rectum, haematopoietic and lymphatic, immune-related, and hormone-related malignancies (<xref ref-type="other" rid="bib10">Gallo <italic>et al</italic>, 2000</xref>; <xref ref-type="other" rid="bib18">Levav <italic>et al</italic>, 2000</xref>). We observed no reduced survival for those cancers in the bereaved parents. Bereaved persons are often subjected to more adverse health behaviours (<xref ref-type="other" rid="bib2">Anda <italic>et al</italic>, 1990</xref>; <xref ref-type="other" rid="bib6">Camacho <italic>et al</italic>, 1991</xref>). However, no reduced survival was found for the digestive system or respiratory cancers. Furthermore, we did not observe any difference in relative mortality rates for cancers with different, <italic>a priori</italic>, expected survival time.</p><p>Our study has a number of advantages. We had access to valid classifications of exposure, and complete follow-up (<xref ref-type="other" rid="bib8">Danish National Board of Health, 2000</xref>; <xref ref-type="other" rid="bib15">Knudsen, 1998</xref>; <xref ref-type="other" rid="bib24">Roed <italic>et al</italic>, 1999</xref>). We used the death of a child as the stress indicator, which has been described as the most intense of all grief with a long-lasting stress effect (<xref ref-type="other" rid="bib22">Osterweis <italic>et al</italic>, 1984</xref>; <xref ref-type="other" rid="bib26">Rubin and Malkinson, 2001</xref>). All bereaved parents in Denmark during the study period were enrolled into the exposed cohort. In addition, all data used in our study were extracted from the databases that were collected independently of the research hypothesis, which minimises the risk of surveillance bias that often is a problem in follow-up studies. Furthermore, we were able to study both overall cancer survival and survival for specific cancers.</p><p>Our study also has limitations. Firstly, we had no information on the stage of the disease when they were diagnosis or for cancer treatment, which are the most important factors for cancer progression. Secondly, we had no information on health behaviours after cancer diagnosis, or compliance to the treatment. Thirdly, the enrolled parents were young and had a low risk of cancer, which yielded limited statistical power especially for subgroups of cancer.</p><p>In summary, we found a slightly reduced survival in bereaved parents and this may be due to confounding. The effect of psychological stress related to bereavement on cancer survival is likely to be small, if any effect exists at all.</p></sec></body><back><ack><p>The activities of the Danish Epidemiology Science Centre are financed by a grant from the Danish National Research Foundation. We thank Mr. J&#x000f8;rn Hansen Schmidt and Mr S&#x000f8;ren Leth-S&#x000f8;rensen at Denmark Statistics for their valuable help in establishing the cohorts. Dr Jiong Li was partly supported by the Daloon Foundation. Dr Christoffer Johansen was supported by the Danish Cancer Society.</p></ack><ref-list><ref id="bib1"><citation citation-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><article-title/><source>Diagnostic and Statistical Manual of Mental Disorders</source><year>1987</year><publisher-name>Washington, DC: National Academy Press</publisher-name></citation></ref><ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anda</surname><given-names>RF</given-names></name><name><surname>Williamson</surname><given-names>DF</given-names></name><name><surname>Escobedo</surname><given-names>LG</given-names></name><name><surname>Mast</surname><given-names>EE</given-names></name><name><surname>Giovino</surname><given-names>GA</given-names></name><name><surname>Remington</surname><given-names>PL</given-names></name></person-group><article-title>Depression and the dynamics of smoking. A national perspective. JAMA</article-title><year>1990</year><volume>264</volume><fpage>1541</fpage><lpage>1545</lpage><!--PubMed citation query: '||264|1541||bib2|'--></citation></ref><ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BL</given-names></name><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>A biobehavioral model of cancer stress and disease course</article-title><source>Am Psychol</source><year>1994</year><volume>49</volume><fpage>389</fpage><lpage>404</lpage><!--PubMed citation query: 'Am Psychol||49|389||bib4|'--><pub-id pub-id-type="pmid">8024167</pub-id></citation></ref><ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buddeberg</surname><given-names>C</given-names></name><name><surname>Wolf</surname><given-names>C</given-names></name><name><surname>Sieber</surname><given-names>M</given-names></name><name><surname>Riehl-Emde</surname><given-names>A</given-names></name><name><surname>Bergant</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>R</given-names></name><name><surname>Landolt-Ritter</surname><given-names>C</given-names></name><name><surname>Richter</surname><given-names>D</given-names></name></person-group><article-title>Coping strategies and course of disease of breast cancer patients Results of a 3-year longitudinal study</article-title><source>Psychother Psychosom</source><year>1991</year><volume>55</volume><fpage>151</fpage><lpage>157</lpage><!--PubMed citation query: 'Psychother Psychosom||55|151||bib5|'--><pub-id pub-id-type="pmid">1891562</pub-id></citation></ref><ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>TC</given-names></name><name><surname>Roberts</surname><given-names>RE</given-names></name><name><surname>Lazarus</surname><given-names>NB</given-names></name><name><surname>Kaplan</surname><given-names>GA</given-names></name><name><surname>Cohen</surname><given-names>RD</given-names></name></person-group><article-title>Physical activity and depression: evidence from the Alameda County Study</article-title><source>Am J Epidemiol</source><year>1991</year><volume>134</volume><fpage>220</fpage><lpage>231</lpage><!--PubMed citation query: 'Am J Epidemiol||134|220||bib6|'--><pub-id pub-id-type="pmid">1862805</pub-id></citation></ref><ref id="bib7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Rabin</surname><given-names>BS</given-names></name></person-group><article-title>Psychologic stress, immunity, and cancer</article-title><source>J Natl Cancer Inst</source><year>1998</year><volume>90</volume><fpage>3</fpage><lpage>4</lpage><!--PubMed citation query: 'J Natl Cancer Inst||90|3||bib7|'--><pub-id pub-id-type="pmid">9428772</pub-id></citation></ref><ref id="bib8"><citation citation-type="book"><person-group person-group-type="author"><collab>Danish National Board of Health</collab></person-group><article-title/><source>Cancer Incidence in Denmark 1997</source><year>2000</year><publisher-name>Copenhagen Danish National Board of Health</publisher-name></citation></ref><ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funch</surname><given-names>DP</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name></person-group><article-title>The role of stress, social support and age in survival from breast cancer</article-title><source>J Psychosom Res</source><year>1983</year><volume>27</volume><fpage>77</fpage><lpage>83</lpage><!--PubMed citation query: 'J Psychosom Res||27|77||bib9|'--><pub-id pub-id-type="pmid">6834302</pub-id></citation></ref><ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>JJ</given-names></name><name><surname>Armenian</surname><given-names>HK</given-names></name><name><surname>Ford</surname><given-names>DE</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Khachaturian</surname><given-names>AS</given-names></name></person-group><article-title>Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States)</article-title><source>Cancer Causes Control</source><year>2000</year><volume>11</volume><fpage>751</fpage><lpage>758</lpage><!--PubMed citation query: 'Cancer Causes Control||11|751||bib10|'--><pub-id pub-id-type="pmid">11065012</pub-id></citation></ref><ref id="bib12"><citation citation-type="book"><person-group person-group-type="author"><collab>International Agency for Research on Cancer World Health Organization, European Commission</collab></person-group><article-title/><source>Survival of Cancer Patients in Europe: the EUROCARE-2 Study</source><year>1999</year><publisher-name>Lyon: Oxford University Press</publisher-name></citation></ref><ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jamison</surname><given-names>RN</given-names></name><name><surname>Burish</surname><given-names>TG</given-names></name><name><surname>Wallston</surname><given-names>KA</given-names></name></person-group><article-title>Psychogenic factors in predicting survival of breast cancer patients</article-title><source>J Clin Oncol</source><year>1987</year><volume>5</volume><fpage>768</fpage><lpage>772</lpage><!--PubMed citation query: 'J Clin Oncol||5|768||bib13|'--><pub-id pub-id-type="pmid">3572466</pub-id></citation></ref><ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Psychoneuroimmunology and cancer: fact or fiction</article-title><source>Eur J Cancer</source><year>1999</year><volume>35</volume><fpage>1603</fpage><lpage>1607</lpage><!--PubMed citation query: 'Eur J Cancer||35|1603||bib14|'--><pub-id pub-id-type="pmid">10673969</pub-id></citation></ref><ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>LB</given-names></name></person-group><article-title>The Danish Fertility Database</article-title><source>Dan Med Bull</source><year>1998</year><volume>45</volume><fpage>221</fpage><lpage>225</lpage><!--PubMed citation query: 'Dan Med Bull||45|221||bib15|'--><pub-id pub-id-type="pmid">9587707</pub-id></citation></ref><ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kvikstad</surname><given-names>A</given-names></name><name><surname>Vatten</surname><given-names>LJ</given-names></name></person-group><article-title>Risk and prognosis of cancer in middle-aged women who have experienced the death of a child</article-title><source>Int J Cancer</source><year>1996</year><volume>67</volume><fpage>165</fpage><lpage>169</lpage><!--PubMed citation query: 'Int J Cancer||67|165||bib16|'--><pub-id pub-id-type="pmid">8760581</pub-id></citation></ref><ref id="bib17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kvikstad</surname><given-names>A</given-names></name><name><surname>Vatten</surname><given-names>LJ</given-names></name><name><surname>Tretli</surname><given-names>S</given-names></name></person-group><article-title>Widowhood and divorce in relation to overall survival among middle-aged Norwegian women with cancer</article-title><source>Br J Cancer</source><year>1995</year><volume>71</volume><fpage>1343</fpage><lpage>1347</lpage><!--PubMed citation query: 'Br J Cancer||71|1343||bib17|'--><pub-id pub-id-type="pmid">7779736</pub-id></citation></ref><ref id="bib18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levav</surname><given-names>I</given-names></name><name><surname>Kohn</surname><given-names>R</given-names></name><name><surname>Iscovich</surname><given-names>J</given-names></name><name><surname>Abramson</surname><given-names>JH</given-names></name><name><surname>Tsai</surname><given-names>WY</given-names></name><name><surname>Vigdorovich</surname><given-names>D</given-names></name></person-group><article-title>Cancer incidence and survival following bereavement</article-title><source>Am J Public Health</source><year>2000</year><volume>90</volume><fpage>1601</fpage><lpage>1607</lpage><!--PubMed citation query: 'Am J Public Health||90|1601||bib18|'--><pub-id pub-id-type="pmid">11029995</pub-id></citation></ref><ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Bagley</surname><given-names>C</given-names></name><name><surname>Lippman</surname><given-names>M</given-names></name></person-group><article-title>Survival hazards analysis in first recurrent breast cancer patients: seven-year follow-up</article-title><source>Psychosom Med</source><year>1988</year><volume>50</volume><fpage>520</fpage><lpage>528</lpage><!--PubMed citation query: 'Psychosom Med||50|520||bib19|'--><pub-id pub-id-type="pmid">3186895</pub-id></citation></ref><ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Johansen</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>D</given-names></name><name><surname>Olsen</surname><given-names>J</given-names></name></person-group><article-title>Cancer incidence in parents who lost a child</article-title><source>Cancer</source><year>2002</year><volume>95</volume><fpage>2237</fpage><lpage>2242</lpage><!--PubMed citation query: 'Cancer||95|2237||bib20|'--><pub-id pub-id-type="pmid">12412179</pub-id></citation></ref><ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macleod</surname><given-names>J</given-names></name><name><surname>Davey</surname><given-names>SG</given-names></name><name><surname>Heslop</surname><given-names>P</given-names></name><name><surname>Metcalfe</surname><given-names>C</given-names></name><name><surname>Carroll</surname><given-names>D</given-names></name><name><surname>Hart</surname><given-names>C</given-names></name></person-group><article-title>Limitations of adjustment for reporting tendency in observational studies of stress and self reported coronary heart disease</article-title><source>J Epidemiol Community Health</source><year>2002</year><volume>56</volume><fpage>76</fpage><lpage>77</lpage><!--PubMed citation query: 'J Epidemiol Community Health||56|76||bib21|'--><pub-id pub-id-type="pmid">11801624</pub-id></citation></ref><ref id="bib22"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Osterweis</surname><given-names>M</given-names></name><name><surname>Solomon</surname><given-names>F</given-names></name><name><surname>Green</surname><given-names>M</given-names></name></person-group><article-title/><source>Bereavement: Reactions, Consequences, and Care</source><year>1984</year><publisher-name>Washington, DC: National Academy Press</publisher-name></citation></ref><ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parkes</surname><given-names>CM</given-names></name></person-group><article-title>Bereavement in adult life</article-title><source>BMJ</source><year>1998</year><volume>316</volume><fpage>856</fpage><lpage>859</lpage><!--PubMed citation query: 'BMJ||316|856||bib23|'--></citation></ref><ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roed</surname><given-names>AS</given-names></name><name><surname>Juhl</surname><given-names>C</given-names></name><name><surname>Kamper-Jorgensen</surname><given-names>F</given-names></name></person-group><article-title>The Danish Prevention Register. A comprehensive health and socio-economic, individual based register</article-title><source>Dan Med Bull</source><year>1999</year><volume>46</volume><fpage>269</fpage><lpage>272</lpage><!--PubMed citation query: 'Dan Med Bull||46|269||bib24|'--><pub-id pub-id-type="pmid">10421986</pub-id></citation></ref><ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>L</given-names></name><name><surname>Boesen</surname><given-names>EH</given-names></name><name><surname>Dalton</surname><given-names>SO</given-names></name><name><surname>Johansen</surname><given-names>C</given-names></name></person-group><article-title>Mind and cancer: does psychosocial intervention improve survival and psychological well-being</article-title><source>Eur J Cancer</source><year>2002</year><volume>38</volume><fpage>1447</fpage><lpage>1457</lpage><!--PubMed citation query: 'Eur J Cancer||38|1447||bib25|'--><pub-id pub-id-type="pmid">12110489</pub-id></citation></ref><ref id="bib26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>SS</given-names></name><name><surname>Malkinson</surname><given-names>R</given-names></name></person-group><article-title>Parental response to child loss across the life cycle: clinical and research perspecitves</article-title><source>Handbook of Bereavement Research: Conequences, Coping, and Care</source><year>2001</year><publisher-name>Washington, DC: American Psychological Association</publisher-name><fpage>219</fpage><lpage>239</lpage>Stroebe MS, Hansson RO, Stroebe W (eds) pp</citation></ref><ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tross</surname><given-names>S</given-names></name><name><surname>Herndon</surname><given-names>J</given-names></name><name><surname>Korzun</surname><given-names>A</given-names></name><name><surname>Kornblith</surname><given-names>AB</given-names></name><name><surname>Cella</surname><given-names>DF</given-names></name><name><surname>Holland</surname><given-names>JF</given-names></name><name><surname>Raich</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Kiang</surname><given-names>DT</given-names></name><name><surname>Perloff</surname><given-names>M</given-names></name><name><surname>Norton</surname><given-names>L</given-names></name><name><surname>Wood</surname><given-names>W</given-names></name><name><surname>Holland</surname><given-names>JC</given-names></name></person-group><article-title>Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B</article-title><source>J Natl Cancer Inst</source><year>1996</year><volume>88</volume><fpage>661</fpage><lpage>667</lpage><!--PubMed citation query: 'J Natl Cancer Inst||88|661||bib27|'--><pub-id pub-id-type="pmid">8627642</pub-id></citation></ref></ref-list></back></article>


